Plasma Homocystein elevelsin subjects with Deep Vein Thrombosis (DVT) and non- DVT

Mehdi Zobeiri; Alireza Hajiabadi; Mansour Rezaei

Journal of Kermanshah University of Medical Sciences

Peer-reviewed Medical Quarterly

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Contact Us Support

Authors Guide Submit Manuscript

Plasma Homocystein elevelsin subjects with Deep Vein Thrombosis (DVT) and non- DVT

Author(s):

Mehdi Zobeiri^1,*,

Alireza Hajiabadi¹,

Mansour Rezaei²

1Dept. of internal medicine, School Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Social Development and Health Promotion Research Center, Dept. of Biostatistics and Epidemiology, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran

Journal of Kermanshah University of Medical Sciences:Vol. 16, issue 4; e78786

Published online:Nov 29, 2012

Article type:Research Article

Received:Nov 05, 2011

Accepted:Feb 28, 2012

How to Cite:Mehdi ZobeiriAlireza HajiabadiMansour RezaeiPlasma Homocystein elevelsin subjects with Deep Vein Thrombosis (DVT) and non- DVT.J Kermanshah Univ Med Sci.16(4):e78786.

Abstract

Background: More recently, hyperhomocysteinemia was considered potentially as a reversible risk factor for venous thromboembolism. Mild hyperhomocysteinemia occurs in approximately 5 to 7 percent of the general population. This study investigates the plasma homocysteine concentration of patients with and without deep venous thrombosis.

Methods: This descriptive case -control study was done on 50 consecutive hospitalised patients with DVT and 50 individuals without DVT. Both groups were equalized with regards to factors such as age, sex, body mass index. The DVT of subjects was diagnosed by Doppler Sonography. Then theirfasting plasma homocysteine was measured.

Results: The mean level of homocysteine in patient and control groups were (20.48 ± 10.30, 18.06±7.67 μmol ∕ lit) respectively which have no statistically significant difference. (p=0.185). Eight % of patients had plasma homocysteine levels above the 95th percentile for the controls, as compared with 4% of the controls with a matched odds ratio of 2.09; 95 % CI: 0.365–11.95. The mean level of plasma homocysteine in individuals with HTN (23.21±10.42) were higher than the others (p<0.05).

Conclusion: The mean plasma homocysteine in both groups was above the normal range, but unlike other studies, there was no difference between them. On the other hand, lower homocysteinelevels in pregnant women who used vitamin supplements (folate) suggest possible cofactor vitamins deficiency at the community level.

Keywords

hyperhomocysteinemia

thromboembolism

risk factor

Fulltext

References

1.
The references of this article is available on PDF.

comments